The multivariate HR for a low expression of CD204+TAMs was 0.43 (1/0.43 = 2.32) indicating a 2.32 times lower chance of tumour recurrence compared with patients with a high expression of CD204+TAMs when controlled for CD4 and chemotherapies; however, this difference did not reach statistical significance (p = 0.091) (Fig. 7). Here, MSR1 is linked to neoplasm.